Health-Related Quality of Life and Cost-Effectiveness Analysis in Radiology

Academic Radiology

Volumn 14, Issue 4, 2007, Pages 411-419

  Kielar, Ania Zofia ^a   El Maraghi, Robert H ^b   Carlos, Ruth C ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b QUEEN S UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC TEST; IMAGING SYSTEM; MEASUREMENT; MEDICAL DECISION MAKING; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; QUALITY OF LIFE; RADIOLOGY; TREATMENT OUTCOME; VISUAL ANALOG SCALE;

COST-BENEFIT ANALYSIS; DIAGNOSTIC IMAGING; EVIDENCE-BASED MEDICINE; HUMANS; OUTCOME ASSESSMENT (HEALTH CARE); QUALITY OF LIFE;

EID: 33947112632     PISSN: 10766332     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.acra.2007.01.003     Document Type: Article

References (36)

1. Nagurney J.T., Brown D.F., Chang Y., Sane S., Wang A.C., and Weiner J.B. Use of diagnostic testing in the emergency department for patients presenting with non-traumatic abdominal pain. J Emerg Med 25 (2003) 363-371
2. Beinfeld M.T., and Gazelle G.S. Diagnostic imaging costs: Are they driving up the costs of hospital care?. Radiology 235 (2005) 934-939
3. Schmale A.H., Morrow G.R., Schmitt M.H., et al. Well-being of cancer survivors. Psychosom Med 45 (1983) 163-169
4. Lewis F.M. Experienced personal control and quality of life in late-stage cancer patients. Nurs Res 31 (1982) 113-119
5. Myerowitz B.E., Sparks F.C., and Spears I.K. Adjuvant chemotherapy for breast carcinoma: Psychosocial implications. Cancer 43 (1979) 1613-1618
6. Hatz P.S., and Powers M.J. Factors related to satisfaction with life for patients on hemodialysis. J Am Assoc Nephrol Nurses Tech 7 (1980) 290-295
7. Gold M.R., Siegel J.E., Russell L.B., and Weinstein M.C. Cost-Effectiveness in Health and Medicine (1996), Oxford University Press, New York 9-49 and 82-98
8. Torrance G.W., Feeny D., and Furlong W. Visual analog scales: Do they have a role in the measurement of preferences for health states?. Med Decis Making 21 (2001) 329-334 4
9. Kumar K., Verma A.K., Wilson J., and LaFontaine A. Vertebroplasty in osteoporotic spine fractures: A quality of life assessment. Can J Neurol Sci 32 (2005) 487
10. Singh A., Pligram T., and Gilula L. Osteoporotic compression fracture: Outcomes after single vs multiple-level percutaneous vertebroplasty. Radiology 238 (2006) 211-220
11. Gray W.A., White Jr. H.J., Barrett D.M., Chandran G., Turner R., and Reisman M. Carotid stenting and endarterectomy: A clinical and cost comparison of revascularization strategies. Stroke 33 (2002) 1063-1070
12. Song S.H., Kim J.K., Song K., Ahn H., and Kim C.S. Effectiveness of local anaesthesia techniques in patients undergoing transrectal ultrasound-guided prostate biopsy: A prospective randomized study. Int J Urol 13 (2006) 707-710
13. Carlos R.C., Axelrod D.A., Ellis J.H., Abrahamse P.H., and Fendrick A.M. Incorporating patient-centered outcomes in the analysis of cost-effectiveness: Imaging strategies for renovascular hypertension. AJR Am J Roentgenol 181 (2003) 1653-1661
14. Carlos R. Introduction to cost-effectiveness analysis in radiology: Principles and practical application. Acad Radiol 11 (2004) 141-148
15. Yazdanpanah Y. Costs associated with combination antiretroviral therapy in HIV-infected patients. J Antimicrob Chemother 53 (2004) 558-561
16. Morimoto T., and Fukui T. Utilities measured by rating scale, time trade-off, and standard gamble: Review and reference for health care professionals. J Epidemiol 12 (2002) 160-178
17. Chapman R.H., Berger M., Weinstein M.C., Weeks J.C., Goldie S., and Neumann P.J. When does quality-adjusted life-years matter in cost effectiveness analysis?. Health Econ 13 (2004) 429-436
18. Hirth R.A., Chernew M.E., Miller E., Fendrick A.M., and Weissert W.G. Willingness to pay for a quality-adjusted life year: In search of a standard. Med Decis Making 20 (2000) 332-342
19. Ubel P.A., Hirth R.A., Chernew M.E., and Fendrick A.M. What is the price of life and why doesn't it increase at the rate of inflation?. Arch Intern Med 163 (2003) 1637-1641
20. Feinberg K.R. Final Report of the Special Master for the September 11th Victim Compensation Fund of 2001 Vol 1 (2004) 1-120
21. Singer M.E., and Applegate K.E. Cost-effectiveness analysis in radiology. Radiology 219 (2001) 611-620
22. Scheurig C., Gauruder-Burmester A., Kluner C., et al. Uterine artery embolization for symptomatic fibroids: Short-term versus mid-term changes in disease-specific symptoms, quality of life and magnetic resonance imaging results. Hum Reprod (2006) Epub ahead of print.
23. Day L. Distributive justice and personal responsibility for choices about health. Am J Crit Care 15 (2006) 96-98
24. Chandler M. The rights of the medically uninsured: An analysis of social justice and disparate health outcomes. J Health Soc Policy 21 (2006) 17-36
25. Manser R., Dalton A., Carter R., Byrnes G., Elwood M., and Campbell D.A. Cost-effectiveness analysis of screening for lung cancer with low dose spiral CT (computed tomography) in the Australian setting. Lung Cancer 48 (2005) 171-185
26. Stout N.K., Rosenberg M.A., Trentham-Deitz A., Smoth M.A., Robinson S.M., and Fryback D.G. Retrospective cost-effectiveness analysis of screening mammography. J Natl Cancer Inst 98 (2006) 774-782
27. Ladabaum U., Song K., and Fendrick A.M. Colorectal neoplasia screening with virtual colonoscopy: When, at what cost, and with what national impact?. Clin Gastroenterol Hepatol 2 (2004) 554-563
28. Beinfeld M.D., Bosch J.L., Isaacson K.B., and Gazelle G.S. Cost-effectiveness of uterine artery embolization and hysterectomy for uterine fibroids. Radiology 230 (2004) 207-213
29. Torgerson D.J., and Raftery J. Discounting. BMJ 319 (1999) 914-915
30. Cairns J. Valuing future benefits. Health Econ 3 (1994) 221-229
31. Bos J., Postma M.J., and Annemans L. Discounting health effects in pharmacoeconomic evaluations: Current controversies. Pharmacoeconomics 23 (2005) 639-649
32. Kent D.M., Fendrick A.M., and Langa A.M. New and dis-improved: On the evaluation and use of less effective, less expensive medical interventions. Med Decis Making 24 (2004) 281-286
33. Swan J.S., Sainfort F., Lawrence W.F., Kuruchittham V., Kongnakorn T., and Heisey D.M. Process utility for imaging in cerebrovascular disease. Acad Radiol 10 (2003) 266-274
34. Swan J.S., and Langlotz C.P. Patient preference for magnetic resonance versus conventional angiography: Assessment methods and implications for cost-effectiveness analysis. Invest Radiol 33 (1998) 553-559
35. Swan J.S., Lawrence W.F., and Roy J. Process utility in breast biopsy. Med Decis Making 26 (2006) 347-359
36. Swan J.S. A software application for multi-attribute utility models. Acad Radiol 11 (2004) 190-205